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Tumor cells generate extracellular superoxide anions and are protected against intercellular apoptosis-
inducing HOCl- and NO/peroxynitrite signaling through the expression of membrane-associated catalase.
This enzyme decomposes H2O2 and thus prevents HOCl synthesis. It efﬁciently interferes with NO/per-
oxynitrite signaling through oxidation of NO and decomposition of peroxynitrite. The regulatory po-
tential of catalase at the crosspoint of ROS and RNS chemical biology, as well as its high local con-
centration on the outside of the cell membrane of tumor cells, establish tight control of intercellular
signaling and thus prevent tumor cell apoptosis. Therefore, inhibition of catalase or its inactivation by
singlet oxygen reactivate intercellular apoptosis-inducing signaling. Nitric oxide and peroxynitrite are
connected with catalase in multiple and meaningful ways, as (i) NO can be oxidated by compound I of
catalase, (ii) NO can reversibly inhibit catalase, (iii) peroxynitrite can be decomposed by catalase and (iv)
the interaction between peroxynitrite and H2O2 leads to the generation of singlet oxygen that inactivates
catalase. Therefore, modulation of the concentration of free NO through addition of arginine, inhibition of
arginase, induction of NOS expression or inhibition of NO dioxygenase triggers an autoampliﬁcatory
biochemical cascade that is based on initial formation of singlet oxygen, ampliﬁcation of superoxide
anion/H2O2 and NO generation through singlet oxygen dependent stimulation of the FAS receptor and
caspase-8. Finally, singlet oxygen is generated at sufﬁciently high concentration to inactivate protective
catalase and to reactivate intercellular apoptosis-inducing ROS signaling. This regulatory network allows
to establish several pathways for synergistic interactions, like the combination of modulators of NO
metabolism with enhancers of superoxide anion generation, modulators of NO metabolism that act at
different targets and between modulators of NO metabolism and direct catalase inhibitors. The latter
aspect is explicitely studied for the interaction between catalase inhibiting acetylsalicylic acid and an NO
donor. It is also shown that hybrid molecules like NO-aspirin utilize this synergistic potential. Our data
open novel approaches for rational tumor therapy based on speciﬁc ROS signaling and its control in
tumor cells.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introductory review
1.1. Extracellular superoxide anion production: a hallmark of ma-
lignant cells
Sustained extracellular superoxide anion production through
membrane-associated NADPH oxidase (NOX) is controlled by ac-
tivated oncogenes and represents a characteristic feature of ma-
lignant cells both in vitro and in vivo [1–18]. Extracellular super-
oxide anions and their dismutation product H2O2 are required forB.V. This is an open access article uthe stimulation of proliferation and for the maintenance of the
transformed state [1,3,5,6,19–21]. Extracellular superoxide anion
generation therefore seems to represent a crucial step in onco-
genesis and a striking example of autocrine stimulation of malig-
nant cells.
The procarcinogenic effects of transformed cell-derived super-
oxide anions are counteracted by versatile superoxide anion-con-
trolled intercellular ROS signaling pathways that cause apoptosis
induction selectively in transformed cells [22–39]. Intercellular
apoptosis-inducing signaling can be established as an interplay
between nontransformed neighbouring effector cells and trans-
formed target cells, or in an autocrine/paracrine signaling by thender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. The HOCl signaling pathway A. Transformed cells. The peroxidase domain
(PODFeIII) (#1) is released from DUOX through the activity of matrix metallopro-
teases (#2). (DUOX is expressed on transformed, nontransformed and tumor cells).
The membrane of malignant cells, but not that of nontransformed cells contains
active NADPH oxidase1 (NOX1) that generates extracellular superoxide anions (#3).
These form H2O2 after dismutation (#4) and are used as substrate by PODFeIII for
the synthesis of HOCl in a two step reaction (#5 and #6) that involves compound I
(PODFeIV¼O  þ) as intermediate. HOCl reacts with NOX1-derived superoxide an-
ions (#7), resulting in the formation of hydroxyl radicals (#8) that cause lipid
peroxidation and subsequent activation of the mitochondrial pathway of apoptosis
(#9). Proton pumps in the cell membrane (#10) favour the generation of HOCl from
OCl . In the presence of excess H2O2 compared to peroxidase, HOCl signaling is
impaired through a catalase-like activity of peroxidase (#11), the reaction between
HOCl and H2O2 (#12) and the reaction between H2O2 and hydroxyl radicals (#13).
B. Tumor cells. Tumor cells carry catalase (CAT) covalently attached to the outside
of their membrane. Catalase decomposes H2O (#5) and thus inhibits HOCl synth-
esis (#6,#7). This prevents HOCl/superoxide anion interaction and formation of
apoptosis-inducing hydroxyl radicals (#8).
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and the selectivity of this elimination mechanism depend on ex-
tracellular superoxide anions that characterize the malignant cells.
Intercellular apoptosis signaling of malignant cells is essentially
mediated by the HOCl and the NO/peroxynitrite signaling pathway
[31,32,34,35,37–39], whereas the nitrylchloride signaling pathway
[43] and the metal catalyzed Haber Weiss reaction [44] are of
minor importance.
Whereas cells transformed in vitro are regularly sensitive for
intercellular ROS-mediated apoptosis induction, bona ﬁde tumor
cells derived from tumors are regularly resistant against inter-
cellular apoptosis signaling, despite activated NOX [40–42]. More
than 70 human tumor cell lines, established from the most fre-
quent and the most aggressive tumors, have been uniformly found
to be protected against NOX-dependent apoptosis signaling
through expression of membrane-associated catalase (39; Bauer,
unpublished).
Acquisition of resistance against ROS represents one char-
acteristic and regularly occurring feature of experimental tumor
progression in vivo [45–49]. The ‘H2O2-catabolizing phenotype’ of
tumor cells, as deﬁned by Deichman and coworkers, correlates
perfectly with resistance against intercellular and autocrine ROS
signalling. Resistance is based on the expression of membrane-
associated catalase that inhibits both central signalling pathways
[40–42].
1.2. Details of the intercellular apoptosis-inducing signaling
pathways
The HOCl and the NO/peroxynitrite signaling pathway have been
elucidated through (i) inhibitor studies, (ii) establishment of models
based on the results of the inhibitor experiments, (iii) veriﬁcation or
falsiﬁcation by reconstitution experiments and (iv) siRNA-based ana-
lysis. The HOCl signaling pathway of transformed cells (Fig. 1A) de-
pends on the extracellular generation of superoxide anions by NOX1,
dismutation of superoxide anions to H2O2 (2O2  þ2Hþ-H2O2þO2),
generation of HOCl by the peroxidase domain of DUOX1 which is
released from DUOX1 through the action of matrix metalloprotease
[50] (H2O2þPODFeIII-PODFeIV¼O  þ þH2O; POD Fe IV¼O  þ þ
ClþHþ-PODFeIIIþHOCl), and the interaction between HOCl and
superoxide anions in the vicinity of the membrane of the target cells
(HOClþO2  - OHþO2þCl) [32,51,52]. The resultant hydroxyl ra-
dical therefore causes lipid peroxidation speciﬁcally in the membrane
of the transformed cells and thus triggers the mitochondrial pathway
of apoptosis, involving caspase-9- and caspase-3 activity [53]. In the
case of excess H2O2 compared to peroxidase, HOCl signaling is strongly
impaired [41,42]. The negative effect of H2O2 on HOCl signaling can be
abrogated by the addition of (i) low concentrations of catalase or cat-
alase mimetics that decompose excess inhibitory H2O2 to a degree
that still allows H2O2-dependent HOCl synthesis, (ii) excess peroxidase
or (iii) NO donors that counteract H2O2-dependent processes [41,42].
The negative effect of excess H2O2 on HOCl signaling might be ex-
plained (i) by a switch of peroxidase activity to catalase activity in
analogy to MPO [54], (ii) the reaction between H2O2 and HOCl (H2O2þ
HOCl-1O2þH2OþHþþCl) [55,56], or (iii) the reaction between
H2O2 and hydroxyl radicals (H2O2þ OH-HO  2þH2O) [57]. The rate
constant of the reaction between H2O2 and hydroxyl radicals (option
iii; reaction #13 in Fig. 1A) is in the order of 107 M1 s1, whereas the
reaction between unsaturated fatty acids in the membrane and hy-
droxyl radicals is two-three orders of magnitude higher. Therefore,
directly at the surface of themembrane, interaction of hydroxyl radicals
with H2O2 is unlikely, in contrast to lipid peroxidation by hydroxyl
radicals. However, in the layer above the cell membrane, deﬁned by the
free diffusion path length of hydroxyl radicals, H2O2 may be speculated
to interact with hydroxyl radicals, due to mobility of both molecules
and immobility of the membrane. Further experimental work isrequired to deﬁne to which extend options (i–iii) from above con-
tribute to the inhibition of the HOCl signaling pathway.
Nontransformed cells that lack activated NOX1 are neither able
to synthesize HOCl nor can they generate hydroxyl radicals after
addition of exogenously added HOCl. Tumor cells prevent HOCl
signaling through expression of membrane-associated catalase
that decomposes H2O2 and thus removes the substrate for POD-
dependent HOCl synthesis (Fig. 1B). Inhibition of catalase, its in-
activation by singlet oxygen or prevention of its expression
through speciﬁc siRNA abrogate its protective effect and allow the
reactivation of HOCl signaling in tumor cells [40–42,53].
The NO/peroxynitrite signaling pathway of transformed cells
depends on cell-derived NO [58–60] and extracellular superoxide
Fig. 2. The NO/peroxynitrite signaling pathway A. Transformed cells. Arginase
controls the level of arginine (#1) which is the substrate for NO synthase (NOS)
(#2). A substantial concentration of NOS-derived NO is converted into NO3
− by NO
dioxygenase (NOD) (#3) that is connected to the activity of cytochrome P 450
oxidoreductase (POR). The remaining NO passes the cell membrane (#4) and reacts
with NOX1-derived superoxide anions (#5), resulting in the formation of perox-
ynitrite (ONOO) (#6). Proton pumps in the cell membrane (#7) favour the pro-
tonation of peroxynitrite to peroxynitrous acid (ONOOH) (#8). Peroxynitrous acid
readily decomposes into NO2 and hydroxyl radicals (#9), which cause lipid per-
oxidation (LPO) (#10) and apoptosis induction through the mitochondrial pathway
of apoptosis (#11). The oxidation of NO by molecular oxygen (#12) leads to the
formation of the peroxynitrite radical (ONOO.), which reacts with NO to form
ONOONO (#13). ONOONO decomposes into 2 NO2 (#14). NO2 reacts with NO to
form dinitrogentrioxide (N2O3) (#15). NOX1 generates extracellular superoxide
anions (#16) that dismutate to H2O2 (#17). HO2
−, the anion of H2O2 (#18) reacts
with N2O3, resulting in the formation of peroxynitrite (#19). The reaction between
peroxynitrite and CO2 (#20, 21) leads to the formation of nitrosoperoxycarboxylate
(ONOOCO2
−) (#22). Nitrosoperoxycarboxylate decomposes into NO2 and the car-
bonate radical (CO3.–) (#23). CO3   reacts with H2O2, resulting in the formation of
HCO3þHO2  (#24), followed by the formation of superoxide anions (#25). NO2
reacts with NO to form N2O3 (#26). The reaction between H2O2 and peroxynitrite
leads to the formation of singlet oxygen (1O2) (#27), whereas the reaction between
H2O2 and hydroxyl radicals (#28, 29) might impair apoptosis induction. B. Tumor
cells. The concentration of extracellular NO is controlled through steps #1–#4, as
discussed under A. Nox1-derived superoxide anions (#5) dismutate to form H2O2
(#6) that is decomposed by membrane-associated catalase (#7), involving com-
pound I as intermediate (CATFeIV¼O  þ). Compound I of catalase is generated
through interaction of native catalase with one molecule of H2O2 and oxidates NO
toNO2
− (#8). Oxidation of NO impairs the formation of ONOO (#9, #10). Residual
ONOO is decomposed by catalase in a two step reaction that involves formation of
compound I (#11). The oxidation of NO and the decomposition of peroxynitrite by
membrane-associated catalase causes a tight control of NO/peroxynitrite signaling.
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controlled by (i) the activity of arginase, (ii) the concentration of
arginine, (iii) the activity of NO synthase (NOS) [58–61], (iv) the
activity of NO dioxygenase (NOD) that oxidizes NO to nitrate [62–
65], and (v) by the oxidation of NO by molecular oxygen [66]. The
diffusion-driven reaction between target cell-derived superoxide
anions and NO ( NOþO2  - ONOO) [67–71] seems to re-
present the central step of the NO/peroxynitrite signaling path-
way, as it can be completely prevented by inhibition of NO
synthesis, inhibition of superoxide anion generation, scavenging of
superoxide anions, as well as by decomposition of peroxynitrite
through decomposition catalysts [34,42]. Protonation of perox-
ynitrite to peroxynitrous acid and homolysis of peroxynitrous
acid into NO2 and apoptosis-inducing hydroxyl radicals
(ONOOþHþ-ONOOH; ONOOH- NO2þ OH) [68, 72–74]
seems to be the ﬁnal step of the NO/peroxynitrite pathway, as
apoptosis induction by this pathway can be completely inhibited
by the hydroxyl radical scavenger mannitol. On a ﬁrst glance, this
ﬁnding is unexpected, as the established chemistry of peroxyni-
trite indicates that the reaction of peroxynitrite with CO2, leading
to the formation of nitrosoperoxycarboxylate (ONOOCOO),
should be more favourable than the formation of peroxynitrous
acid under the experimental conditions used [75–78]. This speciﬁc
aspect will be experimentally illuminated in the Section 4
(Figs. 5 and 6), thereby taking into consideration that malignant
cells show a high activity of proton pumps in their membrane [79].
The resultant high local concentration of protons on the outside of
the cell membrane should facilitate the formation of peroxynitrous
acid form peroxynitrite in direct vicinity of the membrane. Fig. 2 A
shows that NO/peroxynitrite-dependent apoptosis induction may
not only be counteracted by the reaction between peroxynitrite
and CO2 [75–78], but also through the interaction between H2O2
and peroxynitrite [80], the interaction between H2O2 and hydroxyl
radicals [57], the oxidation of NO by oxygen [66] and the reaction
between N2O3 and the anion of H2O2 [81]. These counteracting
pathways are by no means complete and also require additional
discussion. For example, the reaction between H2O2 and hydroxyl
radicals (reaction #28 in Fig. 2A) with a reaction constant in the
order of 107 M1 s1 should have no chance to occur directly at
the surface of the cell membrane, as the rate constant of lipid
peroxidation of unsaturated fatty acids by hydroxyl radicals is two-
to-three orders of magnitude higher. However, experimental evi-
dence presented in reference [53] (inhibition of peroxynitrite/
peroxynitrous acid/hydroxyl radical-dependent apoptosis induc-
tion by excess H2O2 after strong inhibition of tumor cell protective
catalase) shows that this reaction seems to be feasible distant from
the membrane, but within the range of the free diffusion range of
hydroxyl radicals, most likely as the membrane is immobile in
contrast to the reaction partners H2O2 and hydroxyl radical.
Furthermore, reaction # 19 in Fig. 2A is not favoured at neutral
pH, as the pKa of H2O2 is 11.75. In addition, the reaction between
the carbonate radical (CO3  –) and H2O2 (reaction # 24 in Fig. 2A)
may be competed out by the reaction between the carbonate ra-
dical and superoxide anions, which is three orders of magnitude
higher (not shown in Fig. 2A for reduction of complexity).
Nontransformed cells cannot form substantial concentrations
of extracellular peroxynitrite in the presence of NO, as they lack
extracellular superoxide anion production [31–34].
Based on the recently described multifunctionality of catalase
[42,82,83], membrane-associated catalase of tumor cells interferes
with NO/peroxynitrite signaling through oxidation of NO [82,84],
thus interfering with peroxynitrite formation, as well as through
decomposition of peroxynitrite [42,83] (Fig. 2B).
Fig. 3. Mechanistic details of the action of membrane-associated catalase of tumor
cells (A) Tight control of NO/peroxynitrite and HOCl signaling through membrane-
associated catalase of tumor cells. Membrane-associated NOX1 generates extra-
cellular superoxide anions (#1) that form H2O2 after dismutation (#2). H2O2 is
decomposed by membrane-associated catalase in a two step reaction, involving
compound I (CATFeIV¼O  þ) as intermediate (#3 and #4). Thus catalase efﬁciently
inhibits the HOCl signaling pathway as it prevents the generation of HOCl by
peroxidase (#5) and subsequent HOCl/superoxide anion interaction and formation
of apoptosis-inducing hydroxyl radicals (#6). The activity of arginase (#7), the
concentration of its substrate arginine, the activity of NO synthase (NOS) (#8) and
the activity of NO dioxygenase (NOD) (#9) determine the concentration of free NO
(#10). Compound I of catalase (CATFeIV¼O  þ) oxidates NO to NO2− (#11) and thus
counteracts NO-mediated inhibition of catalase (#12), as well as peroxynitrite
formation through NO/superoxide anion interaction (#13). Residual peroxynitrite is
decomposed by catalase in a two step reaction that involves the formation of
compound I (#14 and # 15). Catalase-mediated oxidation of NO and decomposition
of peroxynitrite prevent the formation of peroxynitrous acid (ONOOH) (#16) and its
subseqent decomposition into NO2 and apoptosis-inducing hydroxyl radicals (#17).
Thus catalase establishes a tight control of the NO/peroxynitrite signaling pathway.
(B) Details of the interactions between NO and catalase. NOX-derived superoxide
anions (#1) dismutate to H2O2 (#2) which reacts with native ferricatalase (CATFeIII),
resulting in the formation of compound I (CATFeIV¼O  þ). Compound I is reduced
to the inactive compound II (CATFeIV¼O) by NO in a one electron transfer reaction
(#4). The resultant nitrosonium ion (NOþ) readily reacts with water
(NOþþH2O-2Hþ NO2−) (#5). Compound II reacts with a second molecule of NO
(#6), which leads to the formation of NO2
− and to the restoration of native ferri-
catalase. Taken together, the oxidation of NO by catalase follows the equation
H2O2þ2 NO-2Hþþ2NO2−. The reaction between NO and superoxide anions re-
sults in the formation of peroxynitrite (ONOO) (#7), which reacts with ferrica-
talase and leads to the formation of compound I (#8). If the concentration of NO is
sufﬁciently high, catalase can be reversibly inhibited by NO through formation of
an inactive CATFeIIINO complex (#9). Superoxide anions reactivate NO-inhibited
catalase (#10), but also can cause inhibition of the enzyme (#11) either through
reduction of compound I to the inactive compound II or through formation of in-
active compound III (CATFeIIIO2  ).
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gastric carcinoma cell line MKN-45, ﬁrst allowed reactivation of
NO/peroxynitrite signalling which was followed by reactivation of
the HOCl signalling pathway at higher concentrations of the in-
hibitor. Interestingly, cell lines derived from mammary carcinoma,
Ewing sarcoma, small cell lung carcinoma, neuroblastoma and
ovarial carcinoma showed NO/peroxynitrite signaling exclusively
after inhibition of their protective catalase at all concentrations of
inhibitors ([42,85] Bauer, unpublished results).
1.3. Central role of membrane-associated catalase for the protection
of tumor cells
The combination of membrane-associated NOX1 and extra-
cellular membrane-bound catalase seems to represent a unique
and regular feature of tumor cells (Fig. 3A). NOX1 is the source for
extracellular superoxide anions that (i) are required for the gen-
eration of proliferation-stimulating H2O2, but (ii) also drive the
efﬁciency and selectivity of the HOCl and the NO/peroxynitrite
signaling pathway that endanger the survival of the malignant cell.
Catalase interferes with HOCl and NO/peroxynitrite signaling
through decomposition of H2O2 and peroxynitrite. Both reactions
use compound I (CATFeIV¼O  þ) as intermediate. The proof of
compound I formation by both substrates has been established
through the demonstration of compound I-dependent oxidation of
methanol to formaldehyde after the interaction of either H2O2 or
peroxynitrite with catalase [42]. As shown by Brunelli et al. 2001
[82], catalase has the potential to oxidate NO. Oxidation of NO by
catalase requires ﬁrst the formation of compound I which is fol-
lowed by a two step mechanism, resulting in the overall reaction
H2O2þ2 NO-2Hþþ2NO2− [82,84], with an involvement of com-
pound II (CATFeIV¼O) and NOþ as intermediates (Fig. 3B). Thus,
catalase interferes with peroxynitrite formation in addition to its
potential to decompose peroxynitrite. However, as the formation
of peroxynitrite through superoxide anion/NO interaction is ex-
tremely fast [68–71], whereas the interaction between NO and
catalase seems to be lower [86], decomposition of peroxynitrite
rather than oxidation of NO can be expected to be the major
controlling effect of catalase on NO/peroxynitrite signaling. At
sufﬁciently high concentrations, NO has the potential to reversibly
inhibit catalase by forming an inactive CATFeIIINO complex [87].
Superoxide anions can reactivate NO-inhibited catalase [86], but
also may inhibit catalase through reduction of compound I to the
inactive compound II and through direct interaction with native
ferricatalase, leading to the inactive compound III [88–93]
(Fig. 3B). Thus, extracellular catalase controls the crosspoint be-
tween H2O2 and NO/peroxynitrite-dependent signaling pro-
cesses and at the same time is subject to the control by NO and
superoxide anions.
As catalase can be inhibited by superoxide anions [88–93], the
protective activity of catalase on tumor cells requires the presence
of additional membrane-associated SOD that scavenges super-
oxide anions beyond a level that inhibits catalase [39,94]. As re-
cently shown, the activity of extracellular SOD is low enough to
still allow superoxide anion-dependent interaction with HOCl and
NO, but high enough to prevent superoxide anion-dependent in-
hibition of catalase [39,94].
Recent work shows that transglutaminase 2 is responsible for
the covalent attachment of catalase to the membrane or extra-
cellular matrix, after the enzyme has been released from the tu-
mor cells [95]. The release of catalase from tumor cells per se has
been shown long ago, but has not found much attention in the
past [96,97]. According to our own ﬁndings, these authors have
focussed on free catalase in the supernatants of the cells and may
Fig. 4. Salicylic acid and anthocyanidins use different strategies to inhibit tumor
cell protective catalase. (A) Direct inhibition of catalase by salicylic acid Fig. 4A
combines recent results on the catalatic cycle of catalase for its classical substrate
H2O2 and the alternative substrate peroxynitrite [42] with previously established
central ﬁndings [120]. The catalatic cycle (reactions #1–4) involves the formation of
compound I (CATFeIV¼O  þ) and is extremely fast. It starts and ends with active
ferricatalase (CATFeIII). The interaction between salicylic acid (SA) and catalase
requires the presence of compound I (reaction #5) and is characterized as an one
electron reduction of compound I (CATFeIV¼Oþ  ) to compound II (CATFeIV¼O).
Compound II is inactive with respect to the catalatic cycle, but can interact with a
second molecule of salicylic acid (reaction #6) and thus regenerate active ferrica-
talase (CATFeIII). Reaction steps #5 and #6 represent the peroxidatic cycle of cat-
alase. As the peroxidatic cycle is much slower than the catalatic cycle [120], it re-
sults in (partial) inhibition of catalase and thus allows free H2O2 to get used as
substrate for POD-dependent HOCl synthesis. In parallel, peroxynitrite has a chance
to get protonated and then to generate hydroxyl radicals and NO2. This seems to
restore intercellular ROS-dependent apoptosis signaling through the NO/perox-
ynitrite and the HOCl signaling pathways, which are otherwise controlled by cat-
alase [53]. As further alternative, compound II can be converted to the inactive
compound III (CATFeIIIO2  ) by H2O2, leading to a dead end of catalase activity and
sustained restoration of intercellular ROS signaling. (B) Singlet oxygen-mediated
inactivation of tumor cell protective catalase by anthocyanidins. Anthocyanidins
inhibits NOD (#1) and thus NO generated by NOS (#2) is no longer dioxygenated by
NOD (#3). This causes an increase in free NO (#4), a transient inhibition of catalase
by NO (#5) (87), and an increase in the formation of peroxynitrite (#6). The NO-
mediated inhibition also interferes with catalase-mediated decomposition of H2O2
(#7,8), decomposition of peroxynitrite (#9,10) and oxidation of NO (#11). Therefore,
the concentrations of free H2O2 and peroxynitrite are now increased and a chance
for the generation of singlet oxygen is established (#12). The ligand-independent
activation of the FAS receptor by singlet oxygen [123] and the subsequent caspase-
8-dependent stimulation of NOX activity [124,125] and NOS induction [156] cause a
further increase of NO, superoxide anions, H2O2 and peroxynitrite. They thus am-
plify the generation of more singlet oxygen (#13). Singlet oxygen inactives catalase
(#14) [121,122] and restores efﬁcient signaling through the NO/peroxynitrite (#15,
#16) and the HOCl signaling pathway (#17,#18) and subsequent activation of the
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the membrane. The association of catalase to the membranes en-
sures the high local concentration of the enzyme that is required
for efﬁcient interference with peroxynitrite-dependent effects on
the membrane. As peroxynitrite is generated outside of the tumor
cells, protection against peroxynitrite requires the presence of
catalase at the same site and at appreciable local concentration.
Intracellular catalase cannot interfere with extracellular perox-
ynitrite for the simple reason that peroxynitrite hits the mem-
brane before it could be reached by the intracellular enzyme
[42,95]. This allows a direct and speciﬁc test for extracellular cat-
alase and its inhibition through application of exogenously added
peroxynitrite [53]. The differential role of intra- and extracellular
catalase in the protection of cells against exogenous peroxynitrite
and H2O2 conﬁrmed that protection against exogenous peroxyni-
trite can only be achieved by extracellular catalase, whereas pro-
tection against H2O2 is achieved by intra- and extracellular cata-
lase [95]. Membrane-associated catalase and NOX are not only
interacting as antagonists with respect to intercellular ROS-de-
pendent apoptosis signaling, but they are also connected in a
corresponding response. Inhibition of NOX1 or scavenging of H2O2,
the dismutation product of NOX-derived superoxide anions, causes
a rather rapid decrease in the concentration of protective catalase
[95]. This indicates that high local expression of catalase on the
membrane of tumor cells is not due to stable constitutive ex-
pression but rather reﬂects the result of a dynamic interaction
between cellular superoxide anion/H2O2 production and catalase
expression.
1.4. Inhibition and inactivation of membrane-associated catalase
allows selective apoptosis induction in tumor cells
Inhibition of membrane-associated catalase by 3-aminotriazole
(3-AT) or by neutralizing monoclonal antibodies, as well as siRNA-
mediated prevention of catalase expression caused NOX-driven
reactivation of intercellular apoptosis-inducing NO/peroxynitrite
and HOCl signaling and selective apoptosis induction in tumor
cells [40,42]. A recent study was focussed on apoptosis induction
in tumor cells by secondary plant products, with catalase as hy-
pothetical target structure. The study was based on the long es-
tablished knowledge that salicylic acid [98–104] as well as an-
thocyanidins [105–111] induce apoptosis selectively in malignant
cells in vitro and show antitumor effects in vivo [99,107,112,113]. In
addition, the tumorpreventive effect of acetylsalicylic acid, the i. e.
the prodrug for salicylic acid, has been demonstrated in multiple
studies [114–117]. Salicylic acid-dependent apoptosis induction in
tumor cells does not seem to be attributed to inhibition of cy-
clooxygenase (COX), as salicylic acid also affects COX1- and COX2-
deﬁcient tumor cells [118,119] and as certain other nonsteroidal
antiinﬂammatory drugs that inhibit COX as efﬁciently as salicylic
acid do not induce apoptosis [99]. One common feature of salicylic
acid- and anthocyanidin-dependent apoptosis induction seems to
be the induction of the mitochondrial pathway of apoptosis
[102,103,106,109,111] and the provocation of ROS generation
[102,105,109]. Though salicylic acid is known to inhibit plant and
mammalian catalases through a one electron transfer that trans-
forms compound I into the inactive compound II [120], the inter-
action of salicylic acid with tumor cell protective catalase had not
yet been suggested as potential initial step during salicylic acid-
dependent apoptosis induction in tumor cells. No information on
an effect of anthocyanidins on catalase existed when we started
our study. The paper by Scheit and Bauer 2015 [53] demonstrates
that salicylic acid as well as anthocyanidins (like cyanidin, mal-
vidin, pelargonin and others) cause a strong inhibition of tumor
cell protective catalase and, as a consequence thereof, they re-
activate intercellular apoptosis signaling through the NO/mitochondrial pathway of apoptosis [53].
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the mechanism of catalase inhibition by these two groups of sec-
ondary plant compounds is completely different. Salicylic acid
seemed to inhibit catalase directly and its action did not require
the formation of singlet oxygen. Based on the data from the lit-
erature and our own ﬁndings, reduction of compound I to inactive
compound II or inactive compound III seems to be the mechanism
underlying the inhibitory effect of salicylic acid on catalase
(Fig. 4A). It can easily be seen that the peroxidatic cycle of catalase
through reduction of compound I to compound II and subsequent
restoration of native catalase by a second molecule of salicylic acid
interferes with the catalatic cycle of catalase, but also causes a
gradual consumption of salicylic acid. This decrease was reﬂected
in the kinetics of the salicylic acid dependent effect on tumor cells,
which was indicative of abortive inhibition with time [53]. In-
hibition of catalase by salicylic acid did not require ongoing su-
peroxide anion synthesis, whereas the consquence of inhibition,
i. e. the reactivated intercellular signaling pathways were strictly
dependent on extracellular superoxide anions [53].
In contrast to the action of salicylic acid, the inhibitory effect of
anthocyanidins on catalase was strictly dependent on ongoing
extracellular superoxide anion generation and seemed to be
mediated by singlet oxygen. Singlet oxygen is known for its po-
tential to inactivate catalase through reaction with a histidine re-
sidue close to the active center [121,122]. Based on the results
obtained with sequential addition of inhibitors, the complex pic-
ture shown in Fig. 4B emerged as the most likely mechanism
underlying the inactivation of catalase by anthocyanidins. It is in
line with our data and the known interactions of the molecular
species deﬁned as being involved in this scenario. It represents a
two-step mechanism that utilizes the ampliﬁcatory role of the FAS
receptor that can be activated by singlet oxygen in the absence of
its ligand [123] and that activates NOX1 in a caspase-8-dependent
reaction [124,125]. This caspase-8-dependent activity is different
from the death receptor-mediated cell death process. The experi-
mental dissection between caspase-8-dependent stimulation of
NOX from death receptor-mediated, caspase-8-dependent apop-
tosis induction was possible through utilization of cell lines with
relatively low FAS receptor expression, allowing the FAS-related
effects on ROS signaling but not the direct induction of cell death
through the classical FAS receptor-mediated pathway. As shown in
Fig. 4B, the increase in available NO after inhibition of NOD by an
anthocyanidin is suggested to cause transient inhibition of at least
a few catalase molecules, in line with the ﬁnding by Brown, 1995
[87]. As a consequence, in the vicinity of the inhibited catalase (i)
NO is no longer oxidated, (ii) therefore more peroxynitrite can be
formed and (iii) peroxynitrite and H2O2 are not decomposed by
the enzyme. The interaction between peroxynitrite and H2O2 al-
lows for local formation of singlet oxygen (1O2), in line with the
ﬁndings by Di Mascio et al. (1994) [80], who suggested a direct
interaction of the two molecules as underlying reaction scheme
(H2O2þONOO-1O2 þH2OþNO2–). However, this reaction
seems to be more complex. Therefore, the details of the interaction
are discussed in the Supplementary part of reference# [126].
Singlet oxygen generated after local inhibition of catalase may
either inactivate neighbouring catalase molecules directly or ac-
tivate the FAS receptor in a ligand-independent mode, in line with
the ﬁndings of Zhuang et al., 2001 [123] that were conﬁrmed by
Riethmüller et al., 2015 [126]. As a consequence of FAS receptor
activation, caspase-8-dependent activation of NOX and induction
of NOS expression may lead to an increase of H2O2 and perox-
ynitrite. This ampliﬁcation step allows for more singlet oxygen
generation and subsequent inactivation of catalase molecules to a
degree that allows reactivation of intercellular apoptosis-inducing
signaling.Fig. 4B shows that NO plays central and determining roles
during anthocyanidin-mediated catalase inactivation through this
ampliﬁcatory mechanism and also during subsequent intercellular
apoptosis signaling. The cell lines used for this analysis, like many
other tumor cell lines studied by us, do not carry sufﬁcient FAS
receptor to allow direct induction of FAS receptor-dependent cell
death. Thus it was possible to determine the enhancing effect of
the FAS receptor on the ROS-related signaling pathways leading to
singlet oxygen generation. It is obvious and also was experimen-
tally determined that tumor cell lines with high FAS receptor ex-
pression activate the direct FAS receptor-dependent cell death in
the presence of singlet oxygen, in addtion to the pathways de-
scribed here. However, these interactions reach a degree of com-
plexity that hampers the analysis of discrete signaling pathways.
In the cell system studied here, the FAS receptor and caspase-8
are signaling partners that are not involved in direct induction of
apoptosis, but rather trigger ROS-related signaling pathways that
cause apoptosis indirectly through establishment of intercellular
signaling. Therefore, the effect of caspase-8 is restricted here to the
very early step of catalase inactivation and is not involved in ex-
ecution of cell death through intercellular ROS signaling. The re-
quirement for caspase-8-dependent process was dispensable
when superoxide anion generation was enhanced by stimulation
of NOX1 through TGF-beta1, thus showing that this step was the
contribution of the caspase-8-dependent process required for
catalase inactivation [53,85]
1.5. Synergistic effect between direct and indirect inhibitors/in-
activators of catalase
Fig. 4B indicates that the initial formation of singlet oxygen
from free H2O2 and peroxynitrite after transient NO-mediated
inhibition of catalase is a critical step that requires further am-
pliﬁcation before singlet oxygen-dependent inactivation of cata-
lase can establish a signiﬁcant effect. These initial events are
especially critical, as NO-mediated inhibition of catalase and
singlet oxygen formation are actively counteracted by oxidation of
NO and decomposition of peroxynitrite and H2O2 by residual ac-
tive catalase. The ﬁrst round of activation of the FAS receptor
therefore seems to be a “point of ignition” that triggers further
ROS/RNS interactions that ﬁnally lead to optimal catalase in-
activation and reactivation of intercellular signaling. Even sub-
optimal inactivation of catalase by direct catalase inhibitors such
as salicylic acid might allow local protection of tumor cell-derived
H2O2 and peroxynitrite and thus facilitate the critical initial singlet
oxygen generation. This might enhance further singlet oxygen-
dependent catalase inactivation. Recent results are in line with this
concept, as the combination of salicylic acid with cyanidin caused
an impressive synergistic effect [53,127]. In line with the model
summarized in Fig. 4B, the synergistic effect between salicylic acid
and cyanidin was dependent on the generation of singlet oxygen,
but was independent of the FAS receptor and caspase-8 [127]. It
seemed to follow the steps (1) catalase inactivation, (2) inter-
cellular NOX-dependent signaling through subsequent NO/perox-
ynitrite and HOCl signaling and (3) execution through the mi-
tochondrial pathway of apoptosis, involving caspase-9 and cas-
pase-3. The synergistic effect characterized a rather general prin-
ciple, as different catalase inhibitors (such as neutralizing anti-
bodies against catalase, ascorbic acid, Methyldopa) and anti-SOD
(that causes indirect inhibition of catalase through establishing a
sufﬁciently high concentration of superoxide anion for inhibition
of catalase) had the same effect as salicylic acid when they were
combined with cyanidin or other modulators of the NO metabo-
lism [127].
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on intercellular ROS signaling after catalase inactivation
Several lines of evidence indicate that the apoptosis-inducing
signaling system and its control by catalase as described here
might be relevant for the situation in vivo and therefore might
offer the chance for novel therapeutic approaches:
1. The combination of active NOX1 with membrane-associated
catalase was regularly found in human and animal tumor sys-
tems [38,39];
2. Tumor progression experiments in vivo showed that progres-
sion required the induction and selection of cells that are pro-
tected against H2O2, which was shown to be due to their ex-
pression of membrane-associated catalase [45–49];
3. Inactivation of tumor cell protective catalase reactivated inter-
cellular apoptosis signaling [40–42,53,85],
4. Compounds with selective apoptosis-inducing potential for tu-
mor cells and antitumor activity in vivo, such as salicylate and
anthocyanidins target tumor cell catalase and establish sy-
nergistic effects [53,127].
Therefore, the NO-driven signaling system that establishes
singlet oxygen-dependent inactivation of catalase based on auto-
ampliﬁcatory loops might bear a great chance to establish a ra-
tional and novel approach. Consequently, the solidity of the model
shown in Fig. 4B should be tested by veriﬁcation or falsiﬁcation of
the central deductions based on this model. If the model is correct
and potentially useful for further therapeutic application:
1. modulation of the available NO concentration by (i) an increase
of the NOS substrated arginine, (ii) through inhibition of argi-
nase, (iii) by inducers of NOS expression (iv) by NOD inhibitors
others than anthocyanidins,and (v) by direct application of NO
donors should result in singlet oxygen-dependent catalase in-
activation and subsequent intercellular apoptosis signaling se-
lectively in tumor cells;
2. stepwise experimental dissection of the autoampliﬁcatory loop
shown in Fig. 4B, like addition of exogenous singlet oxygen or
activation of the FAS receptor should allow to reach the same
biological effectas modulation of the NO concentration, i.e.
inactivation of catalase and reactivation of intercellular ROS-
dependent apoptosis signaling;
3. the combination of modulators of NO metabolism with catalase
inhibitors or with stimulators of NADPH oxidase; and the
combination of effector molecules that target different reg-
ulatory points of NO metabolism should establish synergistic
effects on singlet oxygen-dependent catalase inactivation;
4. the combination of catalase inhibitors with exogenous NO, de-
rived from an NO donor should cause a synergistic effect as well
and be directed against tumor cell protective catalase.
The experimental part of this contribution presents the results
of testing the validity of these predictions and also focuses on the
speciﬁc aspect of apoptosis induction mediated by peroxynitrite.2. Experimental complementation
2.1. Materials and methods
2.1.1. Materials
Acetylsalicylic acid, 4-(2-Aminoethyl)benzenesulfonyl ﬂuoride
(AEBSF), 3-aminotriazole (3-AT), arginine, catalase from bovine
liver, cyanidin, cycloheximide (CHX), DEA NONOate, glucose oxi-
dase (GOX), histidine, mannitol, neutralizing monoclonalantibodies against catalase (clone CAT-505, mouse, IgG1), mono-
clonal antibodies directed against laminin, monoclonal antibodies
directed against the EGF receptor, monoclonal antibodies (clone
DX2) directed against human FAS receptor (Apo-1/CD95), the NOS
inhibitor N-omega-nitro-L-arginine methylester hydrochloride (L-
NAME), NO-aspirin (NCX 4040), malvidin, omeprazole, salicylic
acid, taurine, tryptophan, Mn-SOD from Escherichia coli, were ob-
tained from Sigma-Aldrich (Schnelldorf, Germany). The peroxidase
inhibitor 4-Aminobenzoyl hydrazide (ABH) was obtained from
Acros Organics (Geel, Belgium). The catalase mimetic EUK 134
[chloro([2,2′-[1,2-ethanediylbis[(nitrilo-κN)methylidyne]]bis[6-
methoxyphenolato-κO]]]-manganese was a product of Cayman
and was obtained from Biomol (Hamburg, Germany). Inhibitors for
caspase-8 (Z-IETD-FMK) and caspase-9 (Z-LEHD-FMK) were ob-
tained from R&D Systems (Wiesbaden-Nordenstadt, Germany).
The peroxynitrite decomposition catalyst 5-, 10-, 15-, 20-Tetrakis
(4-sulfonatophenyl)porphyrinato iron(III) chloride (FeTPPS) was
obtained from Calbiochem (Merck Biosciences GmbH, Schwal-
bach/Ts, Germany). Photofrin (a product of Axcan, Canada) was
obtained from Meduna Arzneimittel GmbH (Aschaffenburg, Ger-
many). TGF-beta1 was puriﬁed from human platelets as recently
described [22].
Itraconazol (Sempera) was obtained from Janssen-Cilag, Neuss,
Germany. The arginase inhibitors 2(S)-Amino-6-boronohexanoic
acid.NH4 (A-6-BHA), (2S)-(þ)-Amino-5-iodoacetamidopentanoic
acid (A-5-IAAPA), S-(2-Boronoethyl)-L-cysteine.NH4 (BEC),
Nω-Hyroxy-nor-L-arginine.acetate (NOR–NOHA) and NG-Hydr-
oxy-L-arginine.monoacetate (NOHA) were obtained from Axxora/
Enzo Life Sciences, Lörrach, Germany.
Detailed information on inhibitors has been previously pub-
lished [34,40,85,128]. The site of action of inhibitors and sca-
vengers is shown in the supplementary material of Bauer et al.
(2014) [128]; Bauer and Zarkovic (2015) [85].
Preparation of photofrin dilutions and their addition to the
assays was performed at dimmed out light. Singlet oxygen gen-
eration by photofrin was induced by illumination with visible light
under the working bench for the indicated times.2.1.2. Cells and media for cell culture
The human gastric adenocarcinoma cell line MKN-45 (ACC 409)
(established from the poorly differentiated adenocarcinoma of the
stomach (medullary type) of a 62 year-old woman) was purchased
from DSMZ, Braunschweig, Germany. The human Ewing sarcoma cell
lines CHP 100 and A 4573 have been obtained from Dr. U. Kontny,
Department of Pediatrics and Adolescent Medicine, University
Medical Centre Freiburg, Germany. A 4573 cells have deﬁcient ex-
pression of caspase-8 [129]. Nontransformed diploid ﬁbroblasts Al-
pha-1 have been established in our institute from the foreskin of a
healthy proband. MKN-45 and GUMBUS were cultured in RPMI 1640
medium, containing 10% fetal bovine serum (FBS). Fetal bovine ser-
um (Biochrom, Berlin, Germany) had been heated for 30 min at 56 °C
prior to use. Medium was supplemented with penicillin (40 U/ml),
streptomycin (50 mg/ml), neomycin (10 mg/ml), moronal (10 U/ml)
and glutamine (280 mg/ml). Care was taken to avoid cell densities
below 300,000/ml and above 106/ml. L929 and Alpha-1 cells were
cultivated as adherent cultures in Eagle's Minimum Essential Med-
ium (EMEM), supplemented with 5% heat-treated FBS, penicillin
(40 U/ml), streptomycin (50 mg/ml), neomycin (10 mg/ml), moronal
(10 U/ml) and glutamine (280 mg/ml).
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3.1. Apoptosis induction
3.1.1. Autocrine apoptosis induction by intercellular ROS signaling
Cells in complete medium were seeded in 96-well tissue cul-
ture clusters at a density of 12,500 cells/100ml. Reactivation of in-
tercellular apoptosis-inducing ROS signaling required the inhibi-
tion or inactivation of membrane-associated catalase of tumor
cells. This was either achieved by direct catalase inhibitors such as
3-aminotriazole (3-AT) (Figs. 5 and 6A), salicylic acid (Fig. 10) and
acetylsalicylic acid (Fig. 14), or through modulation of the en-
dogenous NO concentration that triggered cell-derived catalase-
inactivating singlet oxygen generation ( Figs. 7–13, 15). Modula-
tion of the NO concentration was achieved through addition ofFig. 5. NO/peroxynitrite signaling is mediated by hydroxyl radicals and not by the
carbonate radical 9000 MKN-45 human gastric carcinoma cells per assay received
no inhibitor (“control”) or the following inhibitors or scavengers: (A) 25 mM of the
peroxynitrite decomposition catalyst FeTPPS, 2.4 mM of the NOS inhibitor L-NAME,
50 mM of the HOCl scavenger taurine (TAU), 100 mM of the NOX inhibitor AEBSF;
(B) 20 mM of the carbonate radical scavenger tryptophan (TRYP), 20 mM of the
hydroxl radical scavenger mannitol (MANN); (C) 25 mM FeTPPS or the indicated
concentrations of mannitol (MANN). 3-AT was added at the indicated concentra-
tions and the percentages of apoptotic cells were determined after 5.5 h. Statistical
analysis: Apoptosis induction by 3.1 – 100 mM 3-AT was highly signiﬁcant
(po0.001). Inhibition of apoptosis by AEBSF and mannitol (between 3 and 100 mM
3-AT), by taurine (25–100 mM) and by L-NAME and FeTPPS (3.1 and 6.2 mM 3-AT)
were highly signiﬁcant (po0.001), whereas there was no signiﬁcant inhibitory
effect by tryptophan.
Fig. 6. Proton pumps control the formation of peroxynitrous acid from peroxyni-
trite A. 9000 MKN-45 cells per assay received either no inhibitor (control) or 25 mM
FeTPPS, 2.8 or 28 mM of the proton pump inhibitor omeprazol (Omepr.) or the
corresponding solvent control (methanol). 3-AT was added at the indicated con-
centrations and the percentages of apoptotic cells were determined after 5.5 h. B.
12500 MKN-45 cells per assay received either no addition (control), or 50 mM 3-AT,
50 mM 3-AT plus 20 mMmannitol (MANN) or 50 mM 3-AT plus 28 mM omeproazol
(omepr.). 100 mM AEBSF was added to all assays and peroxynitrite was added at the
indicated concentrations 15 min later. The percentages of apoptotic cells were
determined after 70 min. Statistical analysis: (A) Apoptosis induction by 3-AT and
its inhibition by 28 mM omeprazole was highly signiﬁcant at all concentrations of
3-AT, whereas there was no signiﬁcant effect of the solvent control. The inhibitory
effect of 2.8 mM omeprazole was highly signiﬁcant between 0.7 and 6.2 mM 3-AT,
the inhibitory effect of FeTPPS was highly signiﬁcant between 0.7 and 12.5 mM
3-AT (po0.001). (B) In the presence of 3-AT, apoptosis induction by 50–200 mM
peroxynitrite and its inhibition by mannitol and omeprazole was highly signiﬁcant
(po0.001).arginine, arginase inhibitors, inhibitors of NO dioxygenase (NOD)
(cyanidin, malvidin), stimulation of the FAS receptor and addition
of interferon gamma. Details of the treatments are summarized in
the respective. In all experiments, assays were performed in du-
plicate. After the indicated time of incubation at 37 °C and 5% CO2
that allowed intercellular ROS-mediated apoptosis induction, the
percentage of apoptotic cells was determined by inverted phase
contrast microscopy based on the classical criteria for apoptosis,
i.e., nuclear condensation/fragmentation or membrane blebbing
[42,130,131]. The characteristic morphological features of intact
and apoptotic cells, as determined by inverted phase contrast
microscopy have been published [29,42,128]. At least 200 neigh-
bouring cells from randomly selected areals were scored for the
percentage of apoptotic cells at each point of measurement. Con-
trol assays ensured that the morphological features ‘nuclear con-
densation/fragmentation’ as determined by inverse phase contrast
microscopy were correlated to intense staining with bisbenzimide
and to DNA strand breaks, detectable by the TUNEL reaction
Fig. 7. Reactivation of intercellular ROS-dependent signaling through addition of
the NOS substrate arginine 12,500 MKN-45 cells per assay received either no ad-
dition (control), 2.5 mM arginine (ARG) or 2.5 mM arginine plus either 2 mM his-
tidine (HIS), 100 mM AEBSF, 2.4 mM L-NAME, 25 mM FeTPPS, 50 mM taurine (TAU),
25 mM caspase-8 inhibitor (CASP8 INH) or 25 mM caspase-9 inhibitor (CASP9 INH).
The inhibitors were either added 15 min before the addition of arginine (A) or
30 min after addition of arginine (B). The percentages of apoptotic cells were de-
termined after 3.5 h. Statistical analysis: Apoptosis induction mediated by arginine
and its inhibition by all inhibitors applied before arginine addition was highly
signiﬁcant (po0.001). When the inhibitors had been applied 30 min after arginine,
only the inhibition by AEBSF, taurine and caspase-9 inhibitor was highly signiﬁcant
(po0.001), whereas the other inhibitors caused no signiﬁcant effects.
Fig. 8. Reactivation of intercellular ROS-dependent signaling through addition of
arginase inhibitors 12,500 MKN-45 tumor cells per assay received the indicated
concentrations of ﬁve chemically different arginase inhibitors. Where indicated,
assays contained 2 mM of the singlet oxygen scavenger histidine (HIS) in addition
to the arginase inhibitors. The percentages of apoptotic cells were determined after
5 h. Abbreviations of arginase inhibitors: A-6-BHA: 2(S)-Amino-6-boronohexanoic
acid.NH4 A-5-IAAPA: (2S)-(þ)-Amino-5-iodoacetamidopentanoic acid BEC:
S-(2-Boronoethyl)-L-cysteine.NH4 NOR-NOHA: Nω-Hyroxy-nor-L-arginine.acetate
NOHA: NG-Hydroxy-L-arginine.monoacetate This experiment demonstrates that
ﬁve different arginase inhibitors cause apoptosis induction in the tumor cells in a
concentration-dependent mode. In each case, apoptosis induction is abrogated
when the singlet oxygen scavenger histidine had been present during treatment.
Statistical analysis: Apoptosis induction by all arginase inhibitors at higher con-
centrations, as well as inhibition by histidine were highly signiﬁcant (po0.001).
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quantitation of apoptotic cells has shown that there is a perfect
coherence between the pattern of cells with condensed/frag-
mented nuclei (stained with bisbenzimide) and TUNEL-positive
cells in assays with substantial apoptosis induction, whereas there
was no signiﬁcant nuclear condensation/fragmentation in control
assays [52,128].
Apoptosis induction by exogenous peroxynitrite is described in
the legend to Figs. 6B and 14 (Fig. 15).
3.2. Irradiation
Cells (200,000 cells/ml in suspension) were irradiated using a
Compagnie Oris (Gif-sur-Yvette, France) IBL 437 Cs137 gamma
source. The dose rate was 37.5 m Gy/s for the experiments in thisstudy. Immediately after irradiation, the cells were centrifuged and
resuspended in fresh medium. The cells were then used either
directly in the experiments or incubated in 5% CO2 at 37 °C in a
humidiﬁed incubator for the time indicated in the and then cen-
trifuged and resuspended in fresh medium.
3.3. Statistics
Statistical analysis. In all experiments, assays were performed
Fig. 9. Activation of the FAS receptror causes the reactivation of intercellular ROS-
mediated apoptosis signalling 12,500 MKN-45 cells per assay received no inhibitors
(control) or 2 mM histidine (HIS), 2.4 mM L-NAME or 50 mM taurine (TAU) either
15 min before or 1 h after addition of the indicated concentrations of antibodies
directed against the FAS receptor. The percentages of apoptotic cells were de-
termined after 12 h. Statistical analysis: Apoptosis induction by anti-FAS receptor as
well as its inhibition by histidine and L-NAME added prior to the antibody were
highly signiﬁcant (po0.001), whereas later addition of these inhibitors did not
cause signiﬁcant inhibition. In contrast, there was no signiﬁcant difference between
the effects of early and late addition of taurine (po0.001) that inhibited apoptosis
induction by anti-FAS receptor up to 10 mg/ml with high signiﬁcance (po0.001).
Fig. 10. Synergistic interaction between the NOD inhibitor cyanidin and catalase
inhibitors. (A) 12,500 MKN-45 cells received no addition (control) or the indicated
concentrations of cyanidin, antibody directed towards the EGF receptor (aEGFR),
neutralizing antibodies directed against human catalase (aCAT) or salicylic acid
(SA). The percentages of apoptotic cells obtained by sole application of these
compounds was determined after 6.5 h. (B) 12,500 MKN-45 cells received no ad-
dition (control) or 0.15 ng/ml cyanidin, 1 ng/ml aEGFR, 1 ng/ml aCAT, 0.1 mg/ml SA
applied alone or 0.15 ng/ml cyanidin combined with either 1 ng/ml aEGFR, 1 ng/ml
aCAT, 0.1 mg/ml SA. The percentages of apoptotic cells were determined after 6 h.
Statistical analysis: (A) Apoptosis induction by cyaniding, aCAT and salicylic acid
was highly signiﬁcant (po0.001). (B) The synergistic effect between cyaniding and
aCAT and cyaniding and salicylic acid was highly signiﬁcant (po0.001).
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Absence of standard deviation bars indicates that the standard
deviation was too small to be reported by the graphic program.
Empirical standard deviations merely demonstrate reproducibility
in parallel assays but do not allow statistical analysis of variance.
The experiments have been repeated at least twice (with duplicate
assays). The Yates continuity corrected chi-square test was
used for the statistical determination of signiﬁcances
(po0.01¼signiﬁcant; po0.001¼highly signiﬁcant).4. Results
4.1. The role of peroxynitritous acid-derived hydroxyl radicals for
apoptosis signaling through the NO/peroxynitrite pathway
In the presence of CO2, the formation of nitrosoperoxycarbox-
ylate (ONOOCOO) from peroxynitrite and subsequentdecomposition into NO2 and carbonate radicals is known as the
dominating reaction [75–78]. Therefore, protonation of peroxyni-
trite to peroxynitrous acid and subsequent decomposition into
NO2 and hydroxyl radicals are generally regarded as being un-
favourable. However, our previous inhibitor experiments with
mannitol pointed to a central role of hydroxyl radicals as ﬁnal
element of the NO/peroxynitrite signaling pathway [42]. In order
to speciﬁcally address this question, MKN-45 cells were treated
with the catalase inhibitor 3-AT in the presence of selected in-
hibitors (Fig. 5). The inhibitor proﬁle (Fig. 5A) showed that
Fig. 11. Synergistic effect between the NOD inhibitor malvidin and low dose
gamma radiation-enhanced superoxide anion generation (A) 12,500 MKN-45 cells
per assay received no inhibitor (control) or 25 mM caspase-8 inhibitor (CASP-8 INH)
either 15 min before or 20 min after the addition of the indicated concentrations of
malvidin. The percentages of apoptotic cells were determined after 12 h. B. MKN-45
cells were irradiated at a density of 200,000 cells/ml with 75 mGy gamma radiation
and incubated for 1 h. The cells were seeded at a density of 12,500 cells per assay
and received no inhibitor (control) or 25 mM caspase-8 inhibitor (CASP-8 INH) ei-
ther 15 before or 20 min after the addition of the indicated concentrations of
malvidin. The percentages of apoptotic cells were determined after 12 h. Statistical
analysis:A: Apoptosis induction by 4 ng/ml and 1000 ng/ml was signiﬁcant
(po0.01), apoptosis induction by 12–330 ng/ml was highly signiﬁcant (po0.001).
Inhibition by caspase-8 inhibitor added 15 min before cyanidin was highly sig-
niﬁcant (po0.001), whereas caspase-8 inhibitor added 25 min after cyanidin only
caused highly signiﬁcant inhibition (po0.001) at 110 ng/ml cyanidin. B: The low
dose irradiation-dependent shift of the curve compared to A was highly signiﬁcant
(po0.001). There was no signiﬁcant inhibition by caspase-8 inhibitor.
Fig. 12. Synergistic effects between the NOS substrate arginine and
H2O2-generating glucose oxidase, the catalase inhibitor salicylic acid and the NOD
inhibitor cyaniding 12,500 MKN-45 cells per assay received no addition (control) or
0.15 mM arginine (ARG), 10 mU/ml glucose oxidase (GOX), 0.1 mg/ml salicylic acid
(SA) or 10 ng/ml cyanidin (CYAN) as individual addition or 0.15 mM arginine
combined with 10 mU/ml glucose oxidase (GOX), 0.1 mg/ml salicylic acid (SA) or
10 ng/ml cyanidin (CYAN). Where indicated, assays had received 2 mM histidine
(HIS) or 25 mM caspase-8 inhibitor (CASP8 INH) 15 min before the other com-
pounds. The percentages of apoptotic cells were determined after 3.5 h. Statistical
analysis: Apoptosis induction by individual compounds was not signiﬁcant,
whereas apoptosis induction through synergistic effects between 0.15 mM arginine
and GOX, salicylic acid and cyanidin, as well as inhibition of apoptosis by histidine
were highly signiﬁcant (po0.001). Caspase-8 inhibitor only cause highly sig-
niﬁcant inhibition of the synergistic effect between cyanidin and arginine
(po0.001).
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concentrations of 3-AT applied, as it was inhibited by the NOX
inhibitor AEBSF. Up to 12.5 mM 3-AT, the NO/peroxynitrite path-
way was dominating, as seen by the inhibitory effect of the per-
oxynitrite decomposition catalyst FeTPPS and the NOS inhibitor L-
NAME. At higher concentrations of 3-AT, HOCl signaling was re-
sponsible for apoptosis induction as shown by the effect of the
HOCl scavenger taurine. As shown in Fig. 5B, scavenging of hy-
droxyl radicals with the speciﬁc scavenger mannitol completely
inhibited apoptosis induction over the whole concentration range
of 3-AT, whereas the carbonate radical scavenger tryptophan had
no inhibitory effect. This ﬁnding conﬁrms the apoptosis-inducing
role of hydroxyl radicals for the NO/peroxynitrite and the HOClsignaling pathway (in line with the schemes shown in Figs. 1 and
2). It also shows that there is no indication for a functional role of
carbonate radicals for apoptosis induction in this speciﬁc context.
When the concentration of mannitol was gradually decreased, the
inhibitory effect on NO/peroxynitrite signaling was gradually
abolished for NO/peroxynitrite signaling, whereas the effect on
HOCl signaling remained much stronger (Fig. 5C).
In order to unravel the paradoxical ﬁnding of biologically sig-
niﬁcant peroxynitrous acid-derived hydroxyl radical generation
despite expected dominating generation of nitrosoperoxycarbox-
ylate (ONOOCOO), we took into consideration that the mem-
brane of tumor cells is known for its high activity of proton pumps
[79]. Therefore, in close vicinity to the membrane, peroxynitrite
might have a higher chance to form peroxynitrous acid rather than
to react with CO2. If this assumption was correct, proton pump
inhibitors should have a negative effect on NO/peroxynitrite sig-
naling. As shown in Fig. 6A, the proton pump inhibitor omeprazol
had a strong inhibitory effect on NO/peroxynitrite signaling and a
weaker effect on HOCl signaling. 28 mM of omeprazol completely
inhibited NO/peroxynitrite signaling and caused more than 50%
inhibition of HOCl signaling. The strong inhibitory effect of ome-
prazol was also seen when exogenous peroxynitrite was applied to
the cells in the presence of 3-AT (Fig. 6B). Thus, interference with
peroxynitrous acid formation had a similar effect as scavenging
peroxynitrous acid-derived hydroxyl radicals by mannitol. The
negative effect of the proton pump inhibitor on HOCl signaling is
Fig. 13. Synergistic action between ﬁve different arginase inhibitors and sub-
optimal concentrations of the NOD inhibitor itraconazole. 12,500 MKN-45 tumor
cells or 10,000 human diploid ﬁbroblasts Alpha-1 per assay were treated without
further additions (“co”), 2 mM of inhibitors 1–4, 4 mM of inhibitor 5 in the absence
or presence of 0.1 mg/ml itraconazol. Where indicated, assays received 2 mM his-
tidine or 100 U/ml Mn-SOD before addition of the other compounds. The percen-
tages of apoptotic cells were determined after ﬁve hours in duplicate experiments.
The data shown in Fig. 13 demonstrate that all arginase inhibitors act synergisti-
cally with itraconzole in the speciﬁc apoptosis induction in tumor cells. The sy-
nergistic action depends on singlet oxygen and superoxide anions, as it was
blocked by histidine as well as SOD. The combination of arginase inhibitors and
itraconazol used in this experiment had no apoptosis inducing effect on normal
diploid ﬁbroblasts. The lack of reaction is due to the lack of extracellular superoxide
anion generation in nontransformed cells. Statistical analysis: A: None of the in-
dividually applied compounds caused signiﬁcant apoptosis induction, whereas the
synergistic effects between itraconazole and the arginase inhibitors were highly
signiﬁcant (po0.001). Inhibition of these synergistic effects by histidine and SOD
were highly signiﬁcant (po0.001). B: There was no signiﬁcant apoptosis induction
in normal human diploid ﬁbroblasts.
Fig. 14. Synergistic effect between the catalase inhibitor acetyl salicylic acid and
the NO donor DEA NONOate 12,500 MKN-45 cells per assay received the indicated
concentrations of acetyl salicylic acid (ASA) alone or in combination with 2 mM
histidine (HIS) (A), or the indicated concentrations of ASA in combination with
0.2 mM DEA NONOate (DEANO.), or the indicated concentrations of ASA in com-
bination with 0.2 mM DEANONOate plus 2 mM histidine (HIS), 100 mM AEBSF,
2.4 mM L-NAME where indicated (B) or the indicated concentrations of the NO-
acetyl salicylic acid hybrid molecule NCX 4040 alone or in combination with 2 mM
histidine (HIS), 100 mM AEBSF, 2.4 mM L-NAME (C). The assays were incubated for
30 min at 37 °C. AEBSF was then added at a concentration of 100 mM (except for the
assays that already contained AEBSF) and 200 mM peroxynitrite (PON) were added
as indicated in the legends. The percentages of apoptotic cells were determined
after 90 min. The ﬁgure shows that ASA sensitizes tumor cells for apoptosis in-
duction by peroxynitrite, i.e. inhibits membrane-associated catalase, independent
of singlet oxygen (A). The presence of the NO donor allows for a synergistic effect
that is dependent on the action of cell-derived singlet oxygen (B). NO-ASA triggers
an effect that is analogous to the synergistic effect between NO and ASA. Statistical
analysis: A: Apoptosis induction by peroxynitrite in the presence of 1–100 mg/ml
acetylsalicylic acid was highly signiﬁcant (po0.001). Histidine did not inhibit this
reaction signiﬁcantly. The difference between assays with and without peroxyni-
trite was highly signiﬁcant (po0.001). (B) The leftward shift of the curve in the
presence of the NO donor DEA NONOate was highly signiﬁcant (po0.001). The
shift-back effect of histidine, AEBSF and L-NAME was highly signiﬁcant (po0.001).
(C) Apoptosis induction by NCX 4040/peroxynitrite in the concentration range
between 0.024 and 6.4 mg/ml NCX 4040 was highly signiﬁcant. The rightward shift
of the curves after addition of histidine, AEBSF and L-NAME was highly signiﬁcant
(po0.001).
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4.2. Triggering of singlet oxygen-dependent reactivation of inter-
cellular apoptosis inducing signaling through the addition of arginine,
arginase inhibitor or exogenous NO
Addition of the NOS substrate arginine at a concentration of
2.5 mM (Fig. 7) caused an analogous apoptosis-inducing effect as
recently described for the NOD inhibitor cyanidin [53]. In analogy
to the mechanism described in Fig. 4B, apoptosis induction trig-
gered by arginine was dependent on an early step that involved
singlet oxygen, NO, peroxynitrite and caspase-8. This was followed
by subsequent HOCl signaling and caspase-9 action. Based on the
reaction schemes and the inhibitor data, superoxide anions (and
their dismutation product H2O2) seem to be required for both
steps.
When the available concentration of arginine was increased by
application of ﬁve chemically different arginase inhibitors (Fig. 8),
in each case a concentration-dependent and singlet oxygen-mediated process of apoptosis induction was initiated. This result
is in line with the result found for the direct application of arginine
and therefore strenghtens the underlying biochemical concept.
The application of 0.2 or 2 mM of the NO donor DEANONOate
did not induce apoptosis in MKN-45 cells, but sensitized the cells
for apoptosis induction by exogenous peroxynitrite, indicating an
inhibitory effect on catalase (Supplementary Fig. 1). When the NO
donor had been added in the presence of the singlet oxygen sca-
venger histidine and the NOX inhibitor AEBSF for prevention of
Fig. 15. Singlet oxygen-dependent and –independent activity of NO-acetyl salicylic
acid. 12,500 MKN-45 cells were treated with increasing concentrations of acetyl
salicylic acid (ASA) (A) or NO-acetyl salicylic acid (NCX 4040) (B) in the absence and
presence of 2 mM histidine (HIS) or 100 mM AEBSF. The percentages of apoptotic
cells were determined after 3.5 h. Statistical analysis: (A) Apoptosis induction by
acetylsalicylic acid (1-40 mg/ml) as well as its inhibition by histidine were highly
signiﬁcant (po0.001). AEBSF caused no signiﬁcant inhibitory effect. (B) The shift of
the concentration-response curve of NCX 4040 compared to acetylsalicylic acid
(A) was highly signiﬁcant, as were the effects of histidine and AEBSF (po0.001).
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the catalase inhibiting effect was partially reduced. This result
allowed to differentiate between direct inhibition of catalase by
NO (in the presence of histidine and AEBSF) and the additional
inactivation through singlet oxygen generation after
peroxynitrite/H2O2 interaction, according to ﬁndings by Di Mascio
et al., 1994 [80] and extended by Riethmüller et al., 2015 [126].
4.3. Activation of the FAS receptor reactivates intercellular ROS-
mediated apoptosis through a singlet oxygen-dependent mechanism
Activation of the FAS receptor by antibodies caused apoptosis
induction dependent on the concentration of the antibodies
(Fig. 9). Apoptosis induction was determined by an early step that
seemed to be mediated by singlet oxygen and NO, as it was in-
hibited by histidine and L-NAME, provided the inhibitors had been
added before the antibodies. Addition of the inhibitors one hour
after the antibodies did not lead to any inhibition. This early stepwas followed by subsequent HOCl-dependent signaling that
caused apoptosis induction and that was independent of NO. Ad-
dition of the HOCl scavenger taurine one hour after the antibodies
caused essentially the same inhibitory effect as its early addition.
There was no detectable direct FAS receptor-dependent apoptosis
induction in the cell line used, as this would be expected to not
being inhibited by scavengers like histidine, L-NAME or taurine.
In line with these and previous ﬁndings, direct application of
exogenous singlet oxygen through illumination of photofrin also
caused reactivation of intercellular apoptosis inducing signaling.
The efﬁciency, selectivity and complexity of this process that is in
line with the model shown in Fig. 4B is presented in [126].
4.4. Inactivation of catalase as common consequence of modulation
of the NO concentration, FAS receptor activation and singlet oxygen
generation
As tumor cells are efﬁciently protected against exogenous H2O2
and peroxynitrite by their membrane-associated catalase, apop-
tosis induction by direct application of these compounds requires
inhibition of the enzyme [40,42,95]. This ﬁnding is illustrated for
H2O2 in Supplementary Fig. 2A. Pretreatment of the tumor cells
with either 5 mM arginine, illuminated photofrin, NOS-inducing
interferon gamma or FAS receptor activating antibodies caused an
analogous sensitization of the cells for apoptosis induction by
H2O2, indicative for the inactivation of catalase (Supplementary
Figs. 2B and 3A–C). This sensitization was completely prevented by
histidine, conﬁrming that it was mediated by singlet oxygen. In-
hibition of the process by the NOS inhibitor L-NAME points to the
expected involvement of NO. Sensitization by arginine occured
despite the presence of the protein synthesis inhibitor cyclohex-
imide, whereas the effects of interferon gamma and the FAS re-
ceptor required ongoing protein synthesis. This may indicate that
the latter effects required induction of NOS expression.
Control experiments with the NO donor DEANONOate con-
ﬁrmed that arginine- and illuminated photofrin-treated cells were
also sensitive for peroxynitrite and that the inactivation of catalase
that sensitized the cells for NO/peroxynitrite-dependent apoptosis
induction had been mediated by singlet oxygen (Supplementary
Fig. 4).
4.5. The establishment of synergistic effects: a chance for efﬁcient
antitumor effects based on the modulation of NO metabolism
The establishment of synergistic effects is a frequently used
approach for therapeutic applications. Its major beneﬁt is a drastic
reduction of the necessary concentrations of compounds involved,
compared to the sole application of individual compounds. Un-
wanted side effects of individual compounds may thus be avoided
and in addition, the approach may become more economic. For
analytical purposes, the unravelling of the mechanisms of sy-
nergistic effects open new chances to understand novel cross
connections in signaling processes. Our previous study [53] has
demonstrated that the direct catalase inhibitor salicylic acid and
the NOD inhibitor cyanidin caused a remarkable synergistic effect.
This ﬁnding is summarized in Fig. 10. Fig. 10A illustrates that high
concentrations of salicylic acid, neutralizing antibody directed
against catalase (aCAT) and cyanidin induce apoptosis in tumor
cells after sole application. Fig. 10B demonstrates that much lower
concentrations of these compounds had no apoptosis-inducing
effect when applied alone, but that the combination of a low
concentration of cyanidin with low concentrations of either aCAT
or salicylic acid established a remarkable synergistic effect. The
combination of cyanidin with control antibody that did not target
catalase had no effect.
The reaction scheme shown in Fig. 4B allowed to predict that
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the biochemical network described might establish useful sy-
nergistic effects. As shown in Fig. 11A, the NOD inhibitor malvidin
caused apoptosis induction in tumor cells in a concentration-de-
pendent mode. The reaction required an early caspase-8-depen-
dent step. When the cells had been pretreated with low dose
gamma irradiation (75 mGy) and allowed to establish bystander-
mediated enhancement of NOX1-dependent superoxide anion
production [132] before malividin was added, a remarkable sy-
nergistic effect was seen (Fig. 11B). Apoptosis induction by the
synergistically acting effectors was independent of caspase-8. This
conﬁrms our previous ﬁnding that the caspase-8-dependent re-
action during singlet oxygen-mediated catalase inactivation was
dispensable when the superoxide anion concentration was in-
creased [52,85]. This ﬁnding also conﬁrmed that in the context of
these experiments caspase-8, was not involved in the execution of
cell death, but that its action was rather restricted to the mod-
ulation of singlet oxygen generation. If this conclusion was correct,
caspase-8-deﬁcient tumor cells should not show apoptosis in-
duction by malvidin applied alone, but should die by apoptosis
after stimulation of NOX1 activity by low dose radiation, which
compensated for the speciﬁc modulatory function of caspase-8.
Supplementary Fig. 5A shows that apoptosis was induced in the
caspase-8-positive Ewing sarcoma cell line CHP100 after malividin
treatment, in a reaction dependent on caspase-8. After establish-
ing a synergistic effect between low dose radiation-mediated sti-
mulation of NOX irradiation and malividin treatment, apoptosis
induction was independent of caspase-8 activity. The caspase-8-
deﬁcient Ewing sarcoma cell line A573 was not affected by treat-
ment with malvidin alone, but showed very efﬁcient apoptosis
induction when low dose radiation and malvidin treatment had
been combined (Supplementary Fig. 5B). This ﬁnding conﬁrms
that caspase-8 plays a modulatory role and that it is dispensable
when NOX is stimulated. Also, caspase-8 seems not to be required
for the execution of apoptosis after intercellular ROS signaling in
this cell system.
In order to clarify whether the contribution by anthocyanidins
to the synergistic effects represented a general aspect of NO rather
than a speciﬁc feature of NOD manipulation, arginine was used as
one of the synergy-establishing partner in the following experi-
ment. The combination of a low concentration of arginine with
either H2O2-generating glucose oxidase, with catalase inhibiting
salicylic acid or with the NOD inhibitor cyanidin caused a sig-
niﬁcant singlet oxygen-dependent synergistic effect in each case
(Fig. 12). Whereas the combination of NO-modulating arginine
with GOX and salicylic acid rendered apoptosis induction in-
dependent of the activity of caspase-8, establishment of a synergy
effect between arginine and cyanidin, i.e. two compounds that
both affected NO concentration, though at different steps, re-
mained dependent on caspase-8 activity. When NO was increased
by the addition of arginase inhibitors, a strong synergistic effect
with the NOD inhibitor itraconazole were observed (Fig. 13), as to
be predicted from the reaction scheme shown in Fig. 4B. Control
experiments thereby ensured that these synergistic effects were
dependent on the action of singlet oxygen and of superoxide an-
ions, and were speciﬁc for tumor cells (Fig. 13B).
4.6. Utilizing NO donors for the establishment of synergistic effects
with a catalase inhibitor
If the conclusions derived from our data were correct, the
combination of a singlet oxygen-independent direct catalase in-
hibitor with an NO donor should also result in a singlet oxygen-
dependent synergistic effect. And if this could be veriﬁed, com-
pounds like NO-aspirin (NO-acetylsalicylic acid) [133,134] might
be discussed as being hybrid molecules that comprise twocompounds necessary for the establishment of a synergistic effect
that targets tumor cell protective catalase. Fig. 14 shows that these
predictions can be conﬁrmed by robust data. Acetylsalicylic acid
sensitized tumor cells for the apoptosis-inducing effect of exo-
genous peroxynitrite, indicating that membrane-associated cata-
lase that decomposes peroxynitrite must have been inhibited or
inactivated (Fig. 14A). In line with the ﬁndings established for
salicylic acid [52], sensitization of tumor cells by acetylsalicylic
acid was independent of singlet oxygen, as it was not prevented by
the singlet oxygen scavenger histidine. DEANONOate applied alone
did not induce apoptosis, as expected by the NO-oxidating and
peroxynitrite-decomposing potential of membrane-associated
catalase. However, the combination of the NO donor with low
concentrations of acetylsalicylic acid caused a remarkable sy-
nergistic effect that was dependent on singlet oxygen, superoxide
anions and NO, as deduced from the inhibitor proﬁle. The NO-
acetylsalicylic acid NCX 4040-induced apoptosis with a similar
efﬁciency as the combination of acetylsalicylic acid and the NO
donor and more than 100 fold more efﬁcient than acetylsalicylic
acid. (Fig. 14C). This efﬁciency was drastically lowered when su-
peroxide anions or singlet oxygen were scavenged or when NOS
was inhibited. The residual singlet oxygen-independent activity of
NCX 4040 in the presence of these inhibitors was indistinguishable
of that of a direct catalase inhibitor. If these conclusions were
correct and sensitization for the apoptosis-inducing effect of per-
oxynitrite did indicate inactivation or inhibition of catalase, then
(i) NCX4040 should induce apoptosis in tumor cells (in the ab-
sence of exogenous peroxynitrite and after longer incubation time
to allow intercellular signaling) with higher efﬁciency than acet-
ylsalicylic and (ii) apoptosis induction by both compounds should
be inhibited by the NOX inhibitor AEBSF, (iii) apoptosis induction
by acetylsalicylic acid should be independent of singlet oxygen and
(iv) apoptosis induction should be dependent on singlet oxygen in
the lower concentration range of NCX 4040 and independent on
singlet oxygen at higher concentrations of NCX 4040. Fig. 15 shows
that all of these predictions were veriﬁed by the performed ex-
periment, demonstrating that NCX 4040 acts as a hybrid com-
posed of two synergistically compounds. A detailed kinetic ana-
lysis of the apoptosis-mediating effect of NCX 4040 illuminated
that NCX 4040 ﬁrst induces a fast singlet oxygen- and NO-de-
pendent process that can be deduced to represent catalase in-
activation, as it allows a longer lasting secondary effect of HOCl
signaling-dependent apoptosis induction that is mediated by su-
peroxide anions, H2O2, peroxidase, HOCl and hydroxyl radicals
(Supplementary Fig. 6).5. Discussion
Reactive oxygen species (ROS) such as superoxide anions, H2O2
and their multiple reaction products, as well as reactive nitrogen
species (RNS) such as NO, ONOO and their complex metabolites
are involved in multistep oncogenesis at many distinct and par-
tially adverse steps [38]. The procarcinogenic effects of ROS com-
prise (i) mutagenic effects related to tumor initiation and tumor
progression [135–137], (ii) ROS-related mechanisms during tumor
promotion [136,138], (iii) establishment and maintenance of the
transformed state through extracellular superoxide anion gen-
eration by membrane-associated NADPH oxidase (NOX1) [1–21],
(iv) changes in the cytoskeleton of transformed cells [139], (v)
induction of cell motility [140], (vi) stimulation of tumor angio-
genesis [141,142] and (vii) enhancement of metastasis [143,144].
Likewise, NO and its multiple derivatives, either derived from the
tumor cells themselves or from cells within the tumor micro-
environment have been shown to contribute to distinct steps of
multistep oncogenesis such as tumor initiation, progression,
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These procarcinogenic effects of ROS and RNS are counteracted
by intercellular apoptosis induction selectively in transformed
cells through the HOCl and the NO/peroxynitrite signaling path-
way (Figs. 1 and 2). These pathways have in common (i) that ex-
tracellular NOX-derived superoxide anions generated speciﬁcally
by transformed cells drive the efﬁciency and the selectivity of
apoptosis induction with respect to the malignant phenotype of
the cells; (ii) that hydroxyl radicals are the ﬁnal apoptosis inducer
through their potential for lipid peroxidation and (iii) that apop-
tosis is mediated by the mitochondrial pathway of apoptosis in-
volving caspase-9 and caspase-3 [53]. As nontransformed cells
lack sustained extracellular superoxide anion generation, they can
neither establish intercellular apoptosis signaling nor are they af-
fected by it. Intercellular apoptosis signaling through the HOCl and
the NO/peroxynitrite signaling pathway has been discussed as
potential mechanism for the elimination of transformed cells
[32,37–39]. Mathematical modelling supports this view [153].
The efﬁciency of the elimination mechanism that is based on
the HOCl and/or NO/peroxynitrite signaling pathway indicates that
tumor formation in vivo should depend on a resistance mechan-
ism to overcome this speciﬁc restraint. Independent and earlier
ﬁndings by Deichman’s group showed that experimental tumor
progression in vivo leads to the selection of a tumor cell pheno-
type that is characterized by its “H2O2-catabolizing potential” [45–
49]. This is in perfect agreement with our recent ﬁndings that
bona vida tumor cells that had been established from tumors were
regularly resistant against intercellular apoptosis induction
through HOCl and NO/peroxynitrite signaling [38–42].Their re-
sistance is based on the expression of membrane-associated cat-
alase that utilizes its location at the right site and its multi-
functionality for the control of both signaling pathways [40,42]
(Fig. 3A). As membrane-associated catalase prevents HOCl signal-
ing through decomposition of H2O2, the substrate required for
peroxidase-mediated HOCl synthesis, and as it interferes with NO/
peroxynitrite signaling through oxidation of NO and decomposi-
tion of peroxynitrite [42], it establishes a tight control of apopto-
sis-inducing signaling.
Inhibition of membrane-associated catalase therefore re-
activates intercellular signaling and thus causes selective apoptosis
induction in tumor cells. After gradual inhibition, tumor cell lines
like MKN-45, Gumbus and many others establish ﬁrst NO/perox-
ynitrite signaling, which is followed by HOCl signaling at higher
concentrations of the catalase inhibitor. In contrast, cell lines de-
rived from neuroblastoma, Ewing sarcoma, small lung cell carci-
noma, mammary carcinoma and ovarial carcinoma establish NO/
peroxynitrite signaling at all concentrations of inhibitor ([39,42] ;
Bauer, unpublished observation).
Due to the efﬁcient reaction between peroxynitrite and CO2,
that leads to the formation of nitrosoperoxycarboxylate [75–78],
the pathway of peroxynitrite to peroxynitrous acid formation and
homolysis into NO2 and hydroxyl radicals [68,72–74] seemed to be
unfavourable. However, the experiments shown in Figs. 5 and 6
strengthen the role of hydroxyl radicals for apoptosis induction, as
the hydroxyl radical scavenger mannitol completely inhibited
apoptosis induction. They also exclude the carbonate radical as
apoptosis inducer, as the carbonate radical scavenger tryptophan
had no inhibitory effect. Our results indicate that the high con-
centration of proton pump-derived Hþ controls peroxynitrous
acid formation in close vicinity to the target membrane and thus
leads to the generation and action of hydroxyl radicals at the re-
quired site. It is reasonable to assume that distant of the cell
membrane, peroxynitrite/CO2 interaction will be the dominant
reaction that most likely hampers the NO/peroxynitrite signaling
pathway.
A recent study showed that two secondary plant products withantitumor activity in vitro and in vivo, i. e. salicylic acid and cya-
nidin, caused inactivation of tumor cell protective catalase and
thus reactivated intercellular apoptosis-inducing signaling through
the HOCl and the NO/peroxynitrite pathway [53]. However, these
compounds used different strategies for the inactivation of cata-
lase, as summarized in Fig. 4A,B. Whereas salicylic acid caused
singlet oxygen-independent direct inactivation of catalase through
formation of inactive compound II and compound III, cyanidin
triggered a complex singlet oxygen-dependent autoampliﬁcatory
mechanism that resulted in singlet oxygen-dependent inactivation
of catalase. The understanding of the initial and crucial step in this
mechanism requires to take into consideration (i) the central role
of catalase for the protection against NO/peroxynitrite signaling
(Fig. 3A), (ii) the multiple modes of NO/catalase interaction, i. e.
oxidation of NO by catalase versus inhibition of catalase by NO
(Fig. 3 B); (iii) the increase in the concentration of free H2O2 and
peroxynitrite after NO-mediated inhibition of catalase (Fig. 4B),
(iv) the generation of singlet oxygen through the reaction between
H2O2 and peroxynitrite [80] and (v) the potential of singlet oxygen
to inactivate catalase [120,121]. Even if the initial concentration of
singlet oxygen generated by this mechanism was too low to allow
substantial inactivation of catalase for reactivation of intercellular
signaling, the potential of singlet oxygen to trigger the FAS re-
ceptor in a ligand independent mode [122] and the FAS receptor/
caspase-8-dependent enhancement of NOX activity and NOS ex-
pression [124,125] ﬁnally seem to establish the generation of
sufﬁciently high concentrations of H2O2, peroxynitrite and their
reaction product singlet oxygen.
Alternatively or in addition to the reaction proposed by Di
Mascio et al., 1994 [80], to explain the generation of singlet oxygen
through the direct interaction between peroxynitrite and H2O2
(H2O2þONOO-1O2 þH2OþNO2), the reaction between hy-
droxyl radicals derived from peroxynitrous acid and H2O2 might
lead to the generation of ·HO2 radicals (H2O2þ OH- HO2þH2O)
[154]. Subsequent spontaneous dismutation of HO2/O2   might
generate singlet oxygen in addition to H2O2 [155]. The signiﬁcance
of these reactions was veriﬁed by Riethmüller et al. (2015) [126].
The validity of this model, derived from the original analysis of
the effect of cyanidin [53] was conﬁrmed through the com-
plementary results presented here, as modulation of the con-
centration of free NO through alternative ways [58–61] such as
addition of arginine, inhibition of arginase, induction of NOS by
interferon gamma also caused singlet oxygen-dependent in-
activation of catalase and subsequent intercellular apoptosis sig-
naling. The ampliﬁcatory role of caspase-8 in the context of this
mechanism was conﬁrmed, as it was shown that caspase-8 was
dispensable when either the generation of superoxide anions was
enhanced by low dose radiation, the concentration of H2O2 was
enhanced through glucose oxidase, or when suboptimal catalase
inhibition was combined with a treatment that increased the
concentration of NO. These ﬁndings and the limitation of the
functional role of caspase-8 to the initial reactions exclude that
caspase-8 was involved in the direct execution of cell death
through activation of a cell death receptor-dependent mechanism.
The restriction of caspase-8 activity to the enhancement of ROS
signaling was experimentally warranted through the use of cell
lines that do not express sufﬁcient FAS receptor for induction of
cell death-dependent apoptosis. When cell lines were used that
had a high expression of the FAS receptor, singlet oxygen gen-
eration after modulation of endogenous NO not only caused cat-
alase inactivation and intercellular apoptosis inducing ROS sig-
naling, but triggered the FAS receptor-dependent pathway in
parallel. This caused an enhancement of apoptosis but was an
obstacle for clear experimental dissection of the individual reac-
tions (Bauer, unpublished observation).
The validity of the model presented in Fig. 4 B is also ensured
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steps, like activation of the FAS rececptor or through addition of
exogenous singlet oxygen, led to the same biochemical endpoints
as starting the cycle with an increase in the concentration of free
NO. In all cases, singlet oxygen-dependent inactivation of catalase
and reactivation of intercellular signaling were the ﬁnal and bio-
logically signiﬁcant consequences. A detailed analysis of the
complex reactions following the addition of exogenous singlet
oxygen is presented by Riethmüller et al. (2015) [126].
The establishment of synergistic effects (i) through the com-
bination of modulators of the NO metabolism (like the NOS sub-
strate arginine or the NOD inhibitors cyanidin and malvidin) with
enhancers of superoxide anion production (like low dose gamma
irradiation) or with H2O2 producing glucose oxidase; (ii) through
the combination of arginase inhibitors with the NOD inhibitor
itraconazole; (iii) through the combination of the NOS substrate
arginine with the NOD inhibitor cyanidin; or (iv) through the
combination of the NOS substrate arginine or the NOD inhibitor
cyanidin with the direct catalase inhibitor salicylic acid is a further
rigid test of the validity of the model presented in Fig. 4B, based on
our recent publication [53]. The establishment of synergistic ef-
fects is therefore highly interesting from an analytical point of
view, but also might open novel approaches for the development
of new antitumor strategies that are (i) speciﬁc with respect to the
malignant phenotype of the targeted cells and (ii) require only
relatively low concentrations of compounds due to the effective-
ness of synergistic effects. This might be one conceivable way to
minimize unwanted side effects.
The synergistic effect between modulators of NO metabolism
and suboptimal concentrations of a catalase inhibitor is especially
intriguing, as it mimicks a situation where a small population of
protective catalase molecules is already inactive and the NO-dri-
ven process is continuously proceeding, leading to further increase
of catalase inactivation through singlet oxygen action. The data
presented here show that the generation of NO by an exogenous
NO donor in combination with the direct catalase inhibitors acetyl
salicylic acid (the prodrug of salicylic acid) is sufﬁcient for the
establishment of the synergistic effect. This conﬁrms the central
role of NO in this process. It also showed that singlet oxygen-in-
dependent inhibition of catalase shifted to a much more effective,
but singlet oxygen-dependent process when acetyl salicylic acid
and the NO donor were combined. In line with this ﬁnding, the
nitric oxide releasing aspirin NCX 4040 [133,134] caused a singlet
oxygen-dependent highly efﬁcient inactivation of catalase which
was shifted to a less efﬁcient direct catalase inhibitory effect re-
lated to the acetyl salicylic acid moiety, when either singlet oxygen
was scavenged or when its generation was prevented. This ﬁnding
indicates that hybrid molecules like NCX 4040 seem to bundle
synergistic effects attributed to the interaction of their sub-
compounds. As NCX 4040 was shown to target catalase and as it
effect was completely abolished when intercellular ROS signaling
was prevented, this compound seems to represent a striking ex-
ample for an therapeutic that utilizes the speciﬁc ROS signaling
chemistry as presented in this manuscript.
Work in progress is focussed on the development of hybrid
molecules that target the NO metabolism and enhance superoxide
anion production, thus ensuring a sustained production of en-
dogenous singlet oxygen at low concentrations of the effector
molecules and a speciﬁc effect on tumor cells with protective
catalase and active NOX. Parallel to the completion of this article,
we have succeeded in the synthesis and analysis of a highly pro-
mising prototype of such a compound.Acknowledgements
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3-AT: 3-Aminotriazole (catalase inhibitor);
ABH: 4-Aminobenzoyl hydrazide (POD inhibitor);
aCAT: Antibody directed towards catalase;
AEBSF: 4-(2-Aminoethyl)benzenesulfonyl ﬂuoride (NOX inhibitor);
ASA: Acetylsalicylic acid;
Casp8: Caspase8;
CAT: Catalase;
CATFeIII: Catalase (native enzyme);
CATFeIV¼Oþ: Compound I of catalase;
CATFeIV¼O: Compound II of catalase;CATFeIIIO2  –: Compound III of catalase;
CATFeIIINO: Catalase/NO complex;
Cpd I, II, III: Compound I, II, III;
DEANO.: DiethylaminoNONOate (NO donor);
DUOX: Dual oxidase;
EUK-134: [chloro([2,2′-[1,2-ethanediylbis[(nitrilo-κN)methylidyne]]bis[6-methox-
yphenolato-κO]]]-manganese (catalase mimetic);
FeTPPS: 5-, 10-, 15-, 20-Tetrakis(4-sulfonatophenyl)porphyrinato iron(III) chloride
(peroxynitrite decomposition catalyst);
GOX: Glucose oxidase;
HIS: Histidine (singlet oxygen scavenger);
ITRA: Itraconazole;
LDR: Low dose gamma radiation;
L-NAME: N-omega-nitro-L-arginine methylester hydrochloride.
(NOS inhibitor)
LPO: Lipid peroxidation;
MANN: Mannitol (hydroxyl radical scavenger);
MMP: Matrix metalloprotease;
MPO: Myeloperoxidase;
NCX 4040: NO-aspirin, NO-acetylsalicylic acid;
NO: Nitric oxide;
NOD: NO dioxygenase;
NOS: NO synthase;
NOX: NADPH oxidase;
Omepr.: Omeprazole (Proton pump inhibitor);
POD: peroxidase;
PODFeIII: peroxidase (native enzyme);
PODFeIV¼O  þ: Compound I of peroxidase;
PODFeIV¼O: Compound II of peroxidase;
PON: Peroxynitrite;
POR: Cytochrome P 450 oxidoreductase;
RNS: Reactive nitrogen species;
ROS: Reactive oxygen species;
SA: Salicylic acid;
siRNA: small interfering RNA;
SOD: Superoxide dismutase;
TAU: Taurine (HOCl scavenger);
TGF-beta1: Transforming growth factor-beta1;
TRYP: Tryptophane (carbonate radical scavenger);
O2  : Superoxide anion;
H2O2: Hydrogen peroxide;
HO2: Anion of hydrogen peroxide;
HO  2: Hydroperoxyl radical;
OH: Hydroxyl radical;
OH: Hydroxyl anion;
1O2: singlet oxygen;
HOCl: Hypochlorous acid;
NO: Nitric oxide;
NO2: Nitrogen dioxide;
NO2: Nitrite;
NO3: Nitrate;
ONOO: Peroxynitrite;
ONOOH: Peroxynitrous acid;
ONOO  : Peroxynitrite radical;
NOþ: Nitrosonium ion;
N2O3: Dinitrogentrioxide;
N2O4: Dinitrogentretraoxide;
ONOONO: Nitrosoperoxy-nitric oxide; isomer of N2O4;
ONOOCOO: Nitrosoperoxycarboxylate;
CO3  : Carbonate radical;
CO32: Carbonate.
